IFNG-AS1 and MAF4 Long Non-Coding RNAs Are Upregulated in Acute Leukemia Patients Who Underwent Bone Marrow Transplantation
Current Research in Translational Medicine
Purpose of the study: Acute graft versus host disease (aGVHD) is an immune-mediated reaction that results in impaired immune and body function after allogeneic hematopoietic stem cell transplantation (allo-HSCT). lncRNAs have been discovered as particular T cell regulators, and alloreactive T cells have been known as a critical factor in aGVHD. As a result, we investigated the importance of lnc-MAF4 and IFNG-AS1 expression levels in aGVHD patients versus non-aGVHD patients. Material and Methods: This research included 38 patients with hematological disorders who were undergoing primary allo-HSCT. Human identical siblings or unrelated donors were used to collect stem cell. Samples were taken within days 0, 7, 14, 28, and 52±8 after transplantation. The expression of lncRNA levels was measured using the QRT-PCR technique. And the data were analyzed using GraphPad Prism 6 Results: Our data revealed that LncRNA MAF4 and INFG-AS1 expression levels in aGVHD were not significantly different compared to the non-GVHD group immediately after transplantation, nor at day 7 or 14. However, the aGVHD group showed an overt up-regulation of the two lncRNAs on samples taken at day 28 and 52±8 compared to non-GVHD patients. Discussion: Since the intracellular pathway of these lncRNAs shows a direct relationship with the IFNγ cytokine production resulting in differentiation to TH1 cells and inhibition of differentiation to TH2 cells, they can be, therefore, considered as suitable molecular candidates for the prediction of aGVHD in patients receiving HSCT.
Jafari, Leila; Izadirad, Mehrdad; Vatanmakanian, Mousa; Ghaedi, Hamid; Farsiani, Mehdi Allahbakhshian; Mohammadi, Mohammad Hossein; Amiri, Vahid; Hosseini, Maryam Sadat; Tavakoli, Farzaneh; azizian, Reza; Gharehbaghian, Ahmad; and Hajifathali, Abbase, "IFNG-AS1 and MAF4 Long Non-Coding RNAs Are Upregulated in Acute Leukemia Patients Who Underwent Bone Marrow Transplantation" (2021). School of Medicine Faculty Publications. 3.